Curcumin gel for abnormal cervical cells linked to HPV
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study tests a topical gel made from curcumin (a compound in turmeric) to see if it can help clear abnormal cervical cells caused by HPV. It may be an option for women with low-grade changes or who have recently had high-grade changes treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have not had your cervix removed (no hysterectomy).
- You have low-grade cervical changes (LSIL) or recently had high-grade changes (HSIL) treated with a LEEP procedure.
- If you have HIV, you must be on treatment with a CD4 count above 200 and an undetectable viral load for at least 3 months.
- You must use reliable birth control (e.g., birth control pills, an IUD, tubal ligation, or Depo-Provera shot).
- You do not have untreated high-grade changes, cervical cancer, or active cervical infections.
- You are not pregnant or breastfeeding and have regular periods.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gel called ACU-D1 for treating high-grade precancerous lesions caused by HPV in the vulvar or perianal area. The goal is to see if the gel can help clear these lesions in people living with HIV.
This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.
This early (Phase 1) study tests a new treatment for people with long-lasting mild abnormal Pap test results (ASC-US or LSIL) who also have HPV16 found on testing. It aims to find out whether the treatment can be given safely and may affect the HPV and abnormal cell changes.
This trial tests a vaginal gel that may help restore the health of the cervix in women with HPV. It aims to see if the gel can improve cervical tissue and potentially help clear the infection.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
Hear when a new Neoplasm Cervix trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.